388 related articles for article (PubMed ID: 34960236)
21. An Overview of Veterinary Viral Diseases and Vaccine Technologies.
Brun A
Methods Mol Biol; 2022; 2465():1-26. PubMed ID: 35118613
[TBL] [Abstract][Full Text] [Related]
22. Classical and Next-Generation Vaccine Platforms to SARS-CoV-2: Biotechnological Strategies and Genomic Variants.
Simões RSQ; Rodríguez-Lázaro D
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206580
[TBL] [Abstract][Full Text] [Related]
23. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine.
Zuckermann FA; Martin S; Husmann RJ; Brandt J
Adv Vet Med; 1999; 41():447-61. PubMed ID: 9890035
[TBL] [Abstract][Full Text] [Related]
24. Exploring the Prospects of Engineered Newcastle Disease Virus in Modern Vaccinology.
Bello MB; Yusoff K; Ideris A; Hair-Bejo M; Jibril AH; Peeters BPH; Omar AR
Viruses; 2020 Apr; 12(4):. PubMed ID: 32316317
[TBL] [Abstract][Full Text] [Related]
25. Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies.
Cid R; Bolívar J
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439738
[TBL] [Abstract][Full Text] [Related]
26. Progress, challenges and opportunities in fish vaccine development.
Adams A
Fish Shellfish Immunol; 2019 Jul; 90():210-214. PubMed ID: 31039441
[TBL] [Abstract][Full Text] [Related]
27. Progress on adenovirus-vectored universal influenza vaccines.
Xiang K; Ying G; Yan Z; Shanshan Y; Lei Z; Hongjun L; Maosheng S
Hum Vaccin Immunother; 2015; 11(5):1209-22. PubMed ID: 25876176
[TBL] [Abstract][Full Text] [Related]
28. Strategic priorities for respiratory syncytial virus (RSV) vaccine development.
Anderson LJ; Dormitzer PR; Nokes DJ; Rappuoli R; Roca A; Graham BS
Vaccine; 2013 Apr; 31 Suppl 2(Suppl 2):B209-15. PubMed ID: 23598484
[TBL] [Abstract][Full Text] [Related]
29. Microneedle patches for vaccine delivery.
Suh H; Shin J; Kim YC
Clin Exp Vaccine Res; 2014 Jan; 3(1):42-9. PubMed ID: 24427762
[TBL] [Abstract][Full Text] [Related]
30. Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis.
Viktorova EG; Khattar SK; Kouiavskaia D; Laassri M; Zagorodnyaya T; Dragunsky E; Samal S; Chumakov K; Belov GA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925653
[TBL] [Abstract][Full Text] [Related]
31. Advances in Development and Application of Influenza Vaccines.
Chen J; Wang J; Zhang J; Ly H
Front Immunol; 2021; 12():711997. PubMed ID: 34326849
[TBL] [Abstract][Full Text] [Related]
32. Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines.
Deering RP; Kommareddy S; Ulmer JB; Brito LA; Geall AJ
Expert Opin Drug Deliv; 2014 Jun; 11(6):885-99. PubMed ID: 24665982
[TBL] [Abstract][Full Text] [Related]
33. [New vaccination strategies].
Plotkin SA
Bull Acad Natl Med; 2008 Mar; 192(3):511-8; discussion 518-9. PubMed ID: 18819697
[TBL] [Abstract][Full Text] [Related]
34. Vaccines and Vaccination for Veterinary Viral Diseases: A General Overview.
Brun A
Methods Mol Biol; 2016; 1349():1-24. PubMed ID: 26458826
[TBL] [Abstract][Full Text] [Related]
35. Toward rational vaccine engineering.
Vishweshwaraiah YL; Dokholyan NV
Adv Drug Deliv Rev; 2022 Apr; 183():114142. PubMed ID: 35150769
[TBL] [Abstract][Full Text] [Related]
36. New viral vectors for infectious diseases and cancer.
Sasso E; D'Alise AM; Zambrano N; Scarselli E; Folgori A; Nicosia A
Semin Immunol; 2020 Aug; 50():101430. PubMed ID: 33262065
[TBL] [Abstract][Full Text] [Related]
37. Application of Traditional Vaccine Development Strategies to SARS-CoV-2.
Rando HM; Lordan R; Lee AJ; Naik A; Wellhausen N; Sell E; Kolla L; ; Gitter A; Greene CS
ArXiv; 2023 Jan; ():. PubMed ID: 36034485
[TBL] [Abstract][Full Text] [Related]
38. Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development.
Hu Z; Lu SH; Lowrie DB; Fan XY
Front Immunol; 2022; 13():895020. PubMed ID: 35812383
[TBL] [Abstract][Full Text] [Related]
39. Japanese encephalitis vaccines: current vaccines and future prospects.
Monath TP
Curr Top Microbiol Immunol; 2002; 267():105-38. PubMed ID: 12082985
[TBL] [Abstract][Full Text] [Related]
40. Clinical Analysis and Applications of mRNA Vaccines in Infectious Diseases and Cancer Treatment.
Ankrah PK; Ilesanmi A; Akinyemi AO; Lasehinde V; Adurosakin OE; Ajayi OH
Cureus; 2023 Oct; 15(10):e46354. PubMed ID: 37920621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
